Tim Lefever, MS, is a seasoned Director and expert in preclinical in vivo research with over 20 years of experience leading highly effective research teams, distinguished by a deep focus on cannabinoid pharmacology and regulatory compliance.

For nine years at the Research Triangle Institute (RTI), he managed complex, federally funded grants and contracts (NIH, FDA, DEA) for research into the structure-activity relationships, abuse liability, pharmacology, and pharmacokinetics of cannabinoids, frequently executing studies under GLP conditions. Tim spent three years at Canopy Growth, where he partnered with the Chief Medical Officer to develop and implement a product safety program, evaluating potential products for safety and efficacy using preclinical in vivo models.

An active contributor to the scientific community, Tim has been a member of the International Cannabinoid Research Society (ICRS) since 2013, co-hosted the Carolina Cannabinoid Collaborative meeting in 2017, currently serves as Treasurer of the Mid-Atlantic Cannabinoid Research Collaborative, and has authored or co-authored numerous scientific manuscripts and conference presentations, underscoring his expert proficiency and leadership in the field.